Eli Lilly News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

14.12.17	Rimidi and Lilly Collaborate to Personalize Solutions for People Using Insulin (PR Newswire)
13.12.17	Lilly Cuts 2017 EPS View; Announces Outlook Through 2020 (RTTNews)
13.12.17	Lilly Announces 2018 Financial Guidance and Enhances Outlook Through 2020 (PR Newswire)
11.12.17	Lilly Announces 8 Percent Dividend Increase (PR Newswire)
11.12.17	Eli Lily: FDA Accepts BLA To Review Galcanezumab For Prevention Of Migraine (RTTNews)
11.12.17	FDA Accepts Biologics License Application (BLA) to Review Galcanezumab for the Prevention of Migraine in Adults (PR Newswire)
11.12.17	Kimberly Blackwell, M.D., to become Vice President of Early Phase Development and Immuno-oncology at Lilly Oncology (PR Newswire)
08.12.17	Lilly Reports Top-Line Results from CYRAMZA® (ramucirumab) Phase 3 Study in First-Line Advanced Gastric Cancer (PR Newswire)
05.12.17	Lilly Initiates Clinical Trial to Evaluate the Functionality and Safety of its Automated Insulin Delivery System (PR Newswire)
01.12.17	Lilly's Taltz® (ixekizumab) Receives U.S. FDA Approval for the Treatment of Active Psoriatic Arthritis (PR Newswire)
21.11.17	Ontario Nurses' Association Welcomes New Members (PR Newswire)
20.11.17	Lilly Confirms Date and Conference Call for 2018 Financial Guidance Announcement (PR Newswire)
17.11.17	Lilly to Participate in Evercore ISI 2017 Biopharma Catalyst/Deep Dive Conference (PR Newswire)
14.11.17	Le Cercle finance et placement du Québec reçoit Arjang Roshan, Président et chef de la direction chez 5N PLUS (PR Newswire)
14.11.17	FDA Nod For AGN, ZYME Strikes A Deal With Janssen Biotech, TCON Abuzz (RTTNews)
14.11.17	Lilly: Jardiance Reduces Risk Of Cardiovascular Death In Type 2 Diabetes And PAD (RTTNews)
14.11.17	Jardiance® reduced risk of cardiovascular death in adults with type 2 diabetes and peripheral artery disease (PR Newswire)
13.11.17	Lilly Appoints Philip Johnson to Senior Vice President and Treasurer (PR Newswire)
10.11.17	Elanco, Aratana Announce Positive Opinion on GALLIPRANT® (grapiprant tablets) in Europe (PR Newswire)
10.11.17	New Data on FORTEO® (teriparatide [rDNA origin] injection) Showed Reduced Risk for New Vertebral and Clinical Fractures in Postmenopausal Women with Severe Osteoporosis (PR Newswire)
08.11.17	ACR/ARHP 2017: Long-Term Use of Lilly's Taltz® (ixekizumab) Shows Efficacy Improvements in Psoriatic Arthritis for Patients with Prior Inadequate Response or Intolerance to TNF Inhibitors (PR Newswire)
06.11.17	Lilly, Incyte: Baricitinib Shows Greater Improvements In Pain Control In RA (RTTNews)
05.11.17	ACR/ARHP 2017: New Analysis Shows Rheumatoid Arthritis Patients Treated with Baricitinib Reported Greater Improvements in Pain Compared to Adalimumab or Placebo (PR Newswire)
03.11.17	Boyd Group Income Fund Announces Completion of Redemption of Convertible Debentures (PR Newswire)
30.10.17	Lilly to Present New Data on Immunology Portfolio at ACR/ARHP Annual Meeting (PR Newswire)
30.10.17	BMO Blue Book: Provinces in Central Canada See Strengthening Growth, Led by Ontario (PR Newswire)
25.10.17	5 Tenets for Successful Robotic Process Automation Deployment (PR Newswire)
25.10.17	Lilly To Participate In Credit Suisse 26th Annual Healthcare Conference (PR Newswire)
24.10.17	Lilly Lifts FY17 View As Q3 Results Top Estimates; Mulls IPO Or Sale Of Elanco (RTTNews)
24.10.17	Eli Lilly And Co. Q3 Earnings Rise 19% (RTTNews)
24.10.17	Lilly Reports Third-Quarter Results, Announces Strategic Review of Elanco Animal Health (PR Newswire)
23.10.17	Eli Lilly Plans To Invest $72 Mln In Insulin Manufacturing Project - Quick Facts (RTTNews)
23.10.17	Lilly announces $72 million investment in diabetes manufacturing in Indianapolis (PR Newswire)
18.10.17	Lilly and CureVac Announce Global Collaboration to Develop mRNA Cancer Vaccines (PR Newswire)
16.10.17	Lilly Declares Fourth-Quarter 2017 Dividend (PR Newswire)
16.10.17	Eli Lilly: REVEL Data Show Efficacy Of Ramucirumab Plus Docetaxel - Quick Factsz (RTTNews)
16.10.17	Rapidly Progressing Advanced Non-Small Cell Lung Cancer Patients Shown to Benefit in New CYRAMZA® (ramucirumab) Phase 3 Subgroup Analysis (PR Newswire)
14.10.17	Indigenous groups, science community, marine industry, and government partners make progress in protecting endangered killer whale population (PR Newswire)
12.10.17	Lilly's Verzenio Gets FDA Priority Review Designation For Advanced Breast Cancer (RTTNews)
12.10.17	FDA Grants Priority Review for Potential New Indication for Lilly's Verzenio™ (abemaciclib) as Initial Treatment of Advanced Breast Cancer (PR Newswire)
11.10.17	CRY Opens Wallet, LLY's JUNIPER Flops, MDXG Catches Eyes, RNN Awaits DATA In Q4 (RTTNews)
10.10.17	Lilly Reports Topline Results from Phase 3 JUNIPER Trial Evaluating Verzenio™ (abemaciclib) in KRAS-Mutated, Advanced Non-Small Cell Lung Cancer (PR Newswire)
10.10.17	InMed Appoints Dr. Mauro Maccarrone to its Scientific Advisory Board (PR Newswire)
09.10.17	New Drugs Approved In September (RTTNews)
06.10.17	Lilly MONARCH 3 Study Published in Journal of Clinical Oncology Demonstrates Benefit of Verzenio™ (abemaciclib) Plus NSAI in Advanced Breast Cancer (PR Newswire)
06.10.17	SK Planet Japan to Launch Geo-Targeted Crypto-Currencies to Attract Booming Chinese Tourists (PR Newswire)
05.10.17	U.S. Patent and Trademark Office Rules In Lilly's Favor On Alimta Vitamin Regimen Patent (PR Newswire)
05.10.17	Additional Delivery of Insulin Ready for Distribution in Puerto Rico (PR Newswire)
05.10.17	MDA Completes Acquisition of DigitalGlobe, Creates Industry Leader in Satellite Systems, Earth Imagery, Geospatial Solutions and Analytics (PR Newswire)
04.10.17	Humalog® Junior KwikPen® Now Available in the U.S. for People with Diabetes (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

20.12.24		Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone
20.12.24		Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones
20.12.24		Dow Jones aktuell: Dow Jones notiert am Mittag im Plus
20.12.24		Verluste in Europa: Euro STOXX 50 letztendlich leichter
20.12.24		Schwacher Handel: SMI schliesst mit Verlusten
20.12.24		Schwache Performance in New York: S&P 500 notiert zum Handelsstart im Minus
20.12.24		Handel in Zürich: SMI verbucht Verluste
20.12.24		Börse Frankfurt: So steht der LUS-DAX am Nachmittag

20.12.24

Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone

20.12.24

Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones

20.12.24

Dow Jones aktuell: Dow Jones notiert am Mittag im Plus

20.12.24

Verluste in Europa: Euro STOXX 50 letztendlich leichter

20.12.24

Schwacher Handel: SMI schliesst mit Verlusten

20.12.24

Schwache Performance in New York: S&P 500 notiert zum Handelsstart im Minus